tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LGND Stock Latest News

Ligand management to meet with Craig-Hallum
The FlyLigand management to meet with Craig-Hallum
20d ago
LGND
Top 5 Trending Stocks by Unusual Trading Volume, 1/14/26
PremiumMarket News
Top 5 Trending Stocks by Unusual Trading Volume, 1/14/26
1M ago
LHX
IRTC
Ligand Pharma Highlights Broad Disclosure of Athira Investment
PremiumCompany Announcements
Ligand Pharma Highlights Broad Disclosure of Athira Investment
2M ago
8K
LGND
Promising Developments and Revenue Prospects Reinforce Buy Rating for Ligand Pharma
PremiumRatings
Promising Developments and Revenue Prospects Reinforce Buy Rating for Ligand Pharma
2M ago
LGND
Ligand Pharma’s Strong Financial Outlook and Strategic Investments Justify Buy Rating
PremiumRatings
Ligand Pharma’s Strong Financial Outlook and Strategic Investments Justify Buy Rating
2M ago
LGND
Ligand price target raised to $230 from $220 at Stifel
PremiumThe FlyLigand price target raised to $230 from $220 at Stifel
2M ago
LGND
Strong Business Model and Growth Potential Drive Buy Rating for Ligand Pharma
Premium
Ratings
Strong Business Model and Growth Potential Drive Buy Rating for Ligand Pharma
2M ago
LGND
Ligand management to meet with Craig-Hallum
Premium
The Fly
Ligand management to meet with Craig-Hallum
3M ago
LGND
Ligand sees FY26 core adjusted EPS view $8.00-$9.00, consensus $7.97
PremiumThe Fly
Ligand sees FY26 core adjusted EPS view $8.00-$9.00, consensus $7.97
3M ago
LGND
Ligand provides updated five-year outlook
PremiumThe Fly
Ligand provides updated five-year outlook
3M ago
LGND
Ligand to host 2025 Investor Day
PremiumThe Fly
Ligand to host 2025 Investor Day
3M ago
LGND
Ligand reiterates 2025 core adjusted EPS view $7.40-$7.65, consensus $7.62
PremiumThe Fly
Ligand reiterates 2025 core adjusted EPS view $7.40-$7.65, consensus $7.62
3M ago
LGND
Ligand Pharma’s Strategic Positioning and Growth Prospects Justify Buy Rating
PremiumRatingsLigand Pharma’s Strategic Positioning and Growth Prospects Justify Buy Rating
3M ago
LGND
Ligand initiated with a Buy at Citi
Premium
The Fly
Ligand initiated with a Buy at Citi
3M ago
LGND
TVTX
Ligand management to meet virtually with Oppenheimer
Premium
The Fly
Ligand management to meet virtually with Oppenheimer
3M ago
LGND
Ligand Pharmaceuticals’ Earnings Call Highlights Strong Growth
PremiumCompany Announcements
Ligand Pharmaceuticals’ Earnings Call Highlights Strong Growth
3M ago
LGND
Ligand price target raised to $234 from $185 at RBC Capital
PremiumThe Fly
Ligand price target raised to $234 from $185 at RBC Capital
4M ago
LGND
Ligand price target raised to $220 from $195 at Stifel
PremiumThe Fly
Ligand price target raised to $220 from $195 at Stifel
4M ago
LGND
Ligand price target raised to $220 from $175 at Benchmark
PremiumThe Fly
Ligand price target raised to $220 from $175 at Benchmark
4M ago
LGND
Ligand price target raised to $275 from $250 at Oppenheimer
PremiumThe FlyLigand price target raised to $275 from $250 at Oppenheimer
4M ago
LGND
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
Premium
The Fly
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
4M ago
BFRI
LGND
Ligand Pharmaceuticals Reports Strong Q3 Results and Raises Guidance
Premium
Company Announcements
Ligand Pharmaceuticals Reports Strong Q3 Results and Raises Guidance
4M ago
LGND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >